Autocrine VEGF-A signaling is reported to increase proliferation and suppress invasion in GBM cells [41]; therefore, elevated Nrp1 expression in GBM cells may be one mechanism to overcome competition between VEGF-A and TGFβ ligands, thus enabling the activation of both pathways simultaneously to promote tumor progression. This evidence concerns the gene TGFB1 and glioblastoma.